Literature DB >> 31356817

OSBPL2 deficiency upregulate SQLE expression increasing intracellular cholesterol and cholesteryl ester by AMPK/SP1 and SREBF2 signalling pathway.

Cui Zhang1, Hongdu Zhang1, Min Zhang1, Changsong Lin1, Hongshun Wang1, Jun Yao2, Qinjun Wei3, Yajie Lu2, Zhibin Chen4, Guangqian Xing4, Xin Cao5.   

Abstract

Previous studies have shown that oxysterol binding protein like 2 (OSBPL2) knockdown is closely related to cholesterol metabolism. However, whether there is a direct relation between OSBPL2 and cholesterol synthesis is unknown. This study explored the mechanism of OSBPL2 deficiency in the upregulation of squalene epoxidase (SQLE) and the subsequent accumulation of intracellular cholesterol and cholesteryl ester. Here, we constructed an OSBPL2-deleted HeLa cell line using CRISPR/Cas9 technology, screened differentially expressed genes and examined the transcriptional regulation of SQLE using a dual-luciferase reporter gene. RNA-seq analysis showed that SQLE was upregulated significantly and the dual luciferase reporter gene assay revealed that two new functional transcription factor binding sites of Sp1 transcription factor (SP1) and sterol regulatory element-binding transcription factor 2 (SREBF2) in the SQLE promoter participated in the SQLE transcription and expression. In addition, we also observed that OSBPL2 deletion inhibited the AMPK signalling pathway and that the inhibition of AMPK signalling promoted SP1 and SREBF2 entry into the nuclear to upregulate SQLE expression. Therefore, these data support that OSBPL2 deficiency upregulates SQLE expression and increases the accumulation of cholesterol and cholesteryl ester by suppressing AMPK signalling, which provides new evidence of the connection between OSBPL2 and cholesterol synthesis.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cholesterol accumulation; OSBPL2; SP1; SQLE; SREBF2

Year:  2019        PMID: 31356817     DOI: 10.1016/j.yexcr.2019.111512

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  7 in total

1.  Oxysterol-binding protein-like 2 contributes to the developmental progression of preadipocytes by binding to β-catenin.

Authors:  Tianming Wang; Tianyu Zhang; Youzhi Tang; Hongshun Wang; Qinjun Wei; Yajie Lu; Jun Yao; Yuan Qu; Xin Cao
Journal:  Cell Death Discov       Date:  2021-05-17

2.  AMP-activated protein kinase activation reduces the transcriptional activity of the murine luteinizing hormone β-subunit gene.

Authors:  Ryutaro Moriyama; Koichi Iwamoto; Teruki Hagiwara; Saishu Yoshida; Takako Kato; Yukio Kato
Journal:  J Reprod Dev       Date:  2019-12-09       Impact factor: 2.214

Review 3.  Cholesterol Metabolism: A Double-Edged Sword in Hepatocellular Carcinoma.

Authors:  Fangli Zhou; Xiaoli Sun
Journal:  Front Cell Dev Biol       Date:  2021-11-10

Review 4.  Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy.

Authors:  Yuheng Zou; Hongying Zhang; Feng Bi; Qiulin Tang; Huanji Xu
Journal:  Front Oncol       Date:  2022-08-24       Impact factor: 5.738

5.  OSBPL2 Is Required for the Binding of COPB1 to ATGL and the Regulation of Lipid Droplet Lipolysis.

Authors:  Tianming Wang; Qinjun Wei; Lihong Liang; Xujun Tang; Jun Yao; Yajie Lu; Yuan Qu; Zhibin Chen; Guangqian Xing; Xin Cao
Journal:  iScience       Date:  2020-06-20

6.  Mutations in OSBPL2 cause hearing loss associated with primary cilia defects via sonic hedgehog signaling.

Authors:  Hairong Shi; Hongshun Wang; Cheng Zhang; Yajie Lu; Jun Yao; Zhibin Chen; Guangqian Xing; Qinjun Wei; Xin Cao
Journal:  JCI Insight       Date:  2022-02-22

7.  High SQLE Expression and Gene Amplification Correlates with Poor Prognosis in Head and Neck Squamous Cell Carcinoma.

Authors:  Lijun Fang; Weixian Liu; Yang Liu
Journal:  Cancer Manag Res       Date:  2021-06-14       Impact factor: 3.989

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.